摘要
新型冠状病毒肺炎(COVID-19)是指由2019新型冠状病毒(2019-nCoV)感染引起的传染性疾病。该疾病传染性较强,人群普遍易感。COVID-19主要通过呼吸道飞沫和密切接触传播,同时也存在气溶胶感染的可能性。目前COVID-19疫情已迅速传播至世界各地,但是临床上对于COVID-19的治疗并无确切的特效药。在疫情发生后,国家卫生健康委员会组织相关专家推出了一系列诊疗方案,从《COVID-19诊疗方案(试行第三版)》开始纳入了中医治疗方案。从《COVID-19诊疗方案(试行第四版)》开始加入了中药注射剂的应用。该文就《COVID-19诊疗方案(试行第七版)》中推荐的喜炎平注射液、热毒宁注射液、痰热清注射液、血必净注射液、参附注射液、参麦注射液、生脉注射液及醒脑静注射液在呼吸系统感染性疾病中的应用进行总结,并对这些中药注射剂在治疗COVID-19中可能起到的作用进行了简单的探讨,以期为中药注射剂在COVID-19治疗中的合理应用提供理论依据。
Coronavirus disease-2019(COVID-19)is an infectious disease caused by 2019 new coronavirus(2019-nCoV)infection.The disease is highly contagious and people are generally susceptible to it.New coronavirus pneumonia is mainly transmitted by respiratory droplets and close contact,but there is also a possibility of aerosol infection.At present,the outbreak of new coronavirus pneumonia has spread rapidly to all parts of the world.However,there is still no specific drug in clinical treatment.After the outbreak,the National Health Commission organized relevant experts to launch a series of diagnosis and treatment programs,including traditional Chinese medicine(TCM)treatment programs from the Trial Version 3.Chinese medicine injections were applied from the Trial Version 4.In this paper,the applications of Chinese medicine injections,which were recommended in the Trial Version 7 of Diagnosis and Treatment Protocol for COVID-19,in respiratory infectious diseases were summarized.Besides,the potential roles of Chinese medicine injections in the treatment of new coronavirus pneumonia were discussed,in order to provide theoretical basis for the reasonable application of Chinese medicine injection in COVID-19 treatment.
作者
刘素彦
王连嵋
赵雍
李春英
梁爱华
LIU Su-yan;WANG Lian-mei;ZHAO Yong;LI Chun-ying;LIANG Ai-hua(Institute of Chinese Materia Medica China Academy of Chinese Medical Sciences,Beijing 100700,China)
出处
《中国实验方剂学杂志》
CAS
CSCD
北大核心
2020年第12期1-13,共13页
Chinese Journal of Experimental Traditional Medical Formulae
基金
国家“重大新药创制”科技重大专项(2015ZX09501004)
中国中医科学院自主选题课题(ZZ-13-035-10,ZZ10025)
中央级公益性科研院所基本科研业务费专项(ZZ13-YQ-055)
中国中医科学院中药研究所项目(ZXKT19014,ZXKT17060,ZXKT17022)。
关键词
新型冠状病毒肺炎
中药注射液
呼吸系统
感染
应用
coronavirus disease-2019
Chinese medicine injection
respiratory system
infection
application
